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e38 Lettersclassification of Clark et al,1 this case suggests that we
should keep verrucous-keratotic malignant
melanoma in mind as an important differential
diagnosis for verrucous, hyperkeratotic lesions. In
this case, the subtle perilesional clinical appearance
of dark infiltration at the ridges might have been a
clue to the diagnosis of melanoma.
The intercellular adhesion between melanoma
cells is much weaker than that between normal
keratinocytes, because melanocytes or melanoma
cells do not have desmosomes. In addition,
membranous expression of E-cadherin, which is
responsible for melanocyte-keratinocyte adhesion,
is sometimes decreased in melanoma progression.2
Thinning of the epidermis with attenuation of
the basal and suprabasal layers, described as
‘‘consumption of the epidermis,’’ is frequently
seen in areas of direct contact between the
epidermis and melanoma cell nests.3 Consumption
of the epidermis occasionally results in the forma-
tion of a cleft separating the thin epidermis and
melanoma cell nests.3 Braun-Falco et al4 reported
that the clefts are a reliable diagnostic criterion for
malignant melanoma. It has been suggested that the
greater the Breslow depth, the greater the con-
sumption of the epidermis in a melanoma lesion.5
However, the Breslow depth of the current lesion
did not appear to be very great, although we were
unable to measure it accurately because of the large
size of the cleft. The presence of the verrucous
architecture may be associated with the presence of
epidermal consumption. In the current case, mela-
noma cells completely replaced the basal layer
keratinocytes, forming only a single-layer lining
on the basement membrane. This characteristic
infiltration pattern of melanoma cells with fragile
cell adhesion might have lead to the large cleft with
features mimicking the tombstone appearance of
pemphigus vulgaris, although in the current lesion,
the tombstones were melanoma cells instead of the
basal keratinocyte tombstones of pemphigus vul-
garis lesions.
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a case associated with inflammatory arthritis
To the Editor: Acral localized acquired cutis laxa
(ALACL) is a distinct variant of acquired cutis laxa
characterized by loose redundant skin primarily
confined to the distal extremities. It is often associated
with signs or symptoms of a preceding inflammatory
dermatosis, such as urticaria, erythema, swelling,
or pruritus. Disease associations include multiple
myeloma, idiopathic urticaria, Raynaud phenome-
non, and rheumatoid arthritis. We report a case
associated with inflammatory arthritis in childhood.
A 41-year-old woman with a history of polyartic-
ular juvenile idiopathic arthritis diagnosed at age 3
presented with asymptomatic loose, pendulous skin
confined to her volar finger pads and toes. She noted
the onset of loose skin at age 6 and described
ill-defined erythema, warmth, and pruritus of her
hands that preceded the development of the skin
changes. The degree of skin laxity remained
stable since childhood. There was no history of
urticaria. Family history was relevant for a paternal
grandfather with rheumatoid arthritis.
On examination, there was loose redundant skin
on the finger pads bilaterally that gave them a flat
rounded appearance (Fig 1). The volar finger pads
were soft on palpation and the skin remained
depressed when pressure was applied, giving them
an appearance that has been described as ‘‘chewing
gum-like.’’1 Theplantar surface of the toes had similar
skin changes, although less striking. Facial appear-
ance was normal and did not show advanced aging.
Fig 1. Acral localized acquired cutis laxa. Loose,
redundant skin on the volar finger pads bilaterally that
gave them a flat, rounded appearance.
Fig 2. Acral localized acquired cutis laxa. Electron
microscopy (330,000) from the skin of the left middle
digit showing fragmented elastic fibers with residual
fragments of electron dense material (black arrows).
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peptide were negative. Plain radiography of the
hands showed stable minor erosive changes. Skin
biopsy samples were obtained from the volar surface
of the left middle finger and unaffected skin on the
left upper arm. The specimen from the left middle
finger showed a marked decrease in elastic fibers.
A neutrophilic inflammatory infiltrate was not iden-
tified, as was observed previously in ALACL.2,3 The
unaffected skin from the left arm showed a normal
number of elastic fibers and normal morphology
under electron microscopy. Ultrastructural examina-
tion of the specimen from the left middle finger
showed elastic fibers fragmented into multiple
electron dense pieces (Fig 2).
ALACLwas first described in 1989 by Fisher et al in
a female patient following urticaria.2 Biopsy from a
urticarial lesion showed neutrophils attached to the
surface of degenerated and normal elastic fibers.2Reed et al hypothesized that elastolysis may result
from degradation by neutrophil elastase.4 The
association of ALACL with inflammatory arthritis in
childhood has not been reported thus far. Rongioletti
et al described a case of ALACL associated with
rheumatoid arthritis and myopathy.5 A recent report
of ALACL demonstrating a perivascular neutrophilic
infiltrate with IgA deposits in superficial dermal
vessels suggested a common pathogenic mechanism
with autoinflammatory syndromes such as Schnitzler
syndrome or adult-onset Still disease.3
Including the case reported, we have identified 13
reports of ALACL in the literature to date.1-3,5-11 Of
patients with ALACL, 54% described a prodrome of
erythema, edema, urticaria, or pruritus involving the
hands. Given the consistent localization and disease
associations, we propose that ALACL be recognized
as a distinct entity within the spectrum of acquired
cutis laxa.
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Successful use of a modified Goeckerman
regimen in the treatment of generalized
prurigo nodularis
To the Editor: Prurigo nodularis (PN) is a severe
morphologic manifestation of chronic pruritus.
Although the exact pathogenesis is unknown, it is
likely that neural sensitization to itch, inflammation,
and trauma contribute to the evolution of PN.
Four patients with recalcitrant generalized PN
were treated with an outpatient modified
Goeckerman regimen 5 days per week at the Uni-
versity of California San Francisco between June
2013 and February 2014 (Table I). All patients had
previously failed standard narrowband or broad-
band UVB therapy. The Goeckerman regimen con-
sisted of daily multiple-step broadband UVB therapy
followed by application of crude coal tar (CCT) and
topical corticosteroids under occlusion for 4 hours
each day. Patients were instructed to apply liquor
carbonis detergens and topical corticosteroids at
home following each session. Treatment was dis-
continued when satisfactory clinical response was
achieved.
Patients underwent a mean 45.5 sessions of
modified Goeckerman therapy, and a mean total
broadband UVB dose of 11.8 J was delivered to the
extremities, the body area receiving the highest UVB
exposure. In patients 1, 2, and 4, pruritus resolved
within the first 5 treatments and nodules flattened
over the following weeks (Fig 1). Patient 3 was noted
to be noncompliant with attendance and home
therapy and demonstrated a more prolonged course
of therapy. The only adverse events were mild
phototoxic reactions that were easily managed by
reduction of the broadband UVB dose.
Following completionof themodifiedGoeckerman
regimen, patients were instructed to continue 3sessions of broadband UVB phototherapy per week
with topical steroids applied to recalcitrant nodules as
needed. Patients 2 and 3 maintained clearance for 8
and 2.5 months before recurrence, respectively, while
patients 1 and 4 remain in remission 5 months and 7
months after treatment at the time of writing.
It is increasingly recognized that neural sensitiza-
tion to itch, neural proliferation, and neurogenic
inflammation are primary components initiating
and maintaining chronic pruritus. Nerve growth
factor (NGF) and calcitonin gene-related peptide
(CGRP) are central mediators implicated in these
processes.1-3 Furthermore, Th2 cell-derived IL-31
mediates pruritus through interaction with neural
IL-31RA.4 PN lesions demonstrate increased levels of
NGF, an increased number of dermal CGRP-positive
nerve fibers, and markedly increased levels of IL-31
mRNA.4-6
UVB radiation reduces levels of NGF and dermal
CGRP-positive nerve fibers.7 It also results in
immunosuppressive effects, which may in turn
reduce levels of IL-31.8 However, all of our patients
failed previous broadband or narrowband UVB
therapy.
It is possible that topical CCT, which produces
anti-inflammatory and antipruritic effects, increases
the efficacy of UVB radiation in PN as demonstrated
in psoriasis. Furthermore, occlusion enhances the
anti-inflammatory and antipruritic effects of topical
corticosteroids, and occlusion itself serves as a
temporary physical barrier interrupting the itch-
scratch cycle.
A modified Goeckerman regimen may be an
effective treatment for PN by targeting both neuro-
logic and inflammatory components of chronic itch.
Based on the efficacy in these patients, dermatolo-
gists should consider Goeckerman therapy for pa-
tients with severe pruritus resulting in PN, even if
they have failed standard phototherapy.
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